MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CARM made $45,250,000 in revenue. $44,717,000 in net income. Net profit margin of 98.82%.

Income Overview

Revenue
$45,250,000
Net Income
$44,717,000
Net Profit Margin
98.82%
EPS
$1.07
Unit: Dollar

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Collaboration revenues
45,250,000 0 3,729,000 3,525,000
Research and development
197,000 2,424,000 9,156,000 16,520,000
General and administrative
1,239,000 3,354,000 3,907,000 5,687,500
Total operating expenses
1,436,000 5,778,000 13,063,000 22,207,500
Operating loss
43,814,000 -5,778,000 -9,334,000 -18,682,500
Gain (loss) on sale of held for sale assets
320,000 -3,539,000 --
Loss on abandonment of operating lease right-of-use asset
0 927,000 --
Interest income, net
--68,000 376,000
Other income, net
583,000 470,000 --
Pre-tax income(loss)
44,717,000 -9,774,000 -9,266,000 -
Income tax expense
0 0 --
Net income(loss)
44,717,000 -9,774,000 -9,266,000 -18,306,500
Comprehensive loss
----18,306,500
Earnings per share, basic
1.07 -0.23 -0.22 -0.44
Earnings per share, diluted
1.07 -0.23 -0.22 -0.44
Weighted average number of shares outstanding, basic
41,788,096 41,788,096 41,771,213 -20,794,061,171.5
Weighted average number of shares outstanding, diluted
41,940,292 41,788,096 41,771,213 -20,794,061,171.5
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Collaboration revenues$45,250,000 Other income, net$583,000 Gain (loss) on sale ofheld for sale assets$320,000 Operating loss$43,814,000 Total operatingexpenses$1,436,000 Pre-tax income(loss)$44,717,000 General andadministrative$1,239,000 Research and development$197,000 Net income(loss)$44,717,000

Carisma Therapeutics Inc. (CARM)

Carisma Therapeutics Inc. (CARM)